How many insider trades does FilingIQ track for RNXT?

FilingIQ tracks 53 Form 4 insider transactions for RNXT (RenovoRx, Inc.), covering filings from Aug 30, 2021 onwards. 11 of those were filed in the last 90 days.

Are RNXT insiders net buyers or net sellers?

Across the full Form 4 history for RNXT, 38 transactions (72%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RNXT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RNXT in?

RenovoRx, Inc. (RNXT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $51.07M.

RNXT insider trading

NasdaqCM Healthcare

RenovoRx, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

72% / 0%

Market cap

$51.07M

About RenovoRx, Inc.

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.

Company website: renovorx.com

RNXT insider activity at a glance

FilingIQ has scored 53 insider transactions for RNXT since Aug 30, 2021. The most recent filing in our index is dated Apr 3, 2026.

Across the full history, 38 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RNXT insider trades is 61.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live RNXT trades on FilingIQ Raw filings on SEC EDGAR

Latest RNXT Form 4 filings

VOLL MARK Chief Financial Officer

P Mar 20, 2026

Bagai Shaun Chief Executive Officer

P Mar 20, 2026

Bagai Shaun Chief Executive Officer

P Jan 26, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading RNXT

VOLL MARK

4 trades · score 78.0

Bagai Shaun

5 trades · score 70.7

Frequently asked

How many insider trades does FilingIQ track for RNXT?: FilingIQ tracks 53 Form 4 insider transactions for RNXT (RenovoRx, Inc.), covering filings from Aug 30, 2021 onwards. 11 of those were filed in the last 90 days.
Are RNXT insiders net buyers or net sellers?: Across the full Form 4 history for RNXT, 38 transactions (72%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RNXT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RNXT in?: RenovoRx, Inc. (RNXT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $51.07M.

Methodology & sources

Every RNXT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.